Ep. 611 "What the Pill & Depo Do to Your Bones" | Menopause, Perimenopause, Bone Health

Welcome to the latest Midlife Minute.

Today, we’re discussing how oral contraceptives and Depo Provera can impact women’s bone health over time.Stay tuned as I walk you through the research, prescribing trends, and ways women can support their bone health.

IN THIS EPISODE, YOU WILL LEARN:

• How peak bone mass in adolescence affects bone health later in life

• How oral contraceptives can interfere with the bone development of young women

• The lack of informed conversations about the bone health risks associated with long-term contraceptive use

• Why Depo Provera may have a stronger impact on bone density than oral contraceptives

• The importance of nutrition and strength training for supporting bone health

• How hormonal contraceptives can affect the gut microbiome and immune system

• What you need to consider regarding your bone density and long-term health if you’ve been using oral contraceptives or Depo for many years

Connect with Cynthia Thurlow  

• Follow on X, Instagram & LinkedIn

• Check out Cynthia’s website.

• Submit your questions to support@cynthiathurlow.com 

• Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow. 

• Purchase Cynthia’s book, The Menopause Gut.

• Cynthia’s Intermittent Fasting Transformation Book

• The Midlife Pause Supplement Line

Resources:

• Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls doi:10.1016/j.jadohealth.2004.07.005

• Oral Contraceptive Use and Bone Density Change in Adolescent and Young Adult Women: A Prospective Study of Age, Hormone Dose, and Discontinuation doi:10.1210/jc.2010-3027

  
  

• Adolescent use of combined hormonal contraception and peak bone mineral density accrual: A meta-analysis of international prospective controlled studies doi:10.1111/cen.13932

• No need to specialize: reproductive health is for all adolescents doi:10.1016/j.jpag.2006.01.055

• Injectable Hormone Contraception and Bone Density: Results from a Prospective Study doi:10.1097/00001648-200209000-00015

• Hormonal contraception and the development of autoimmunity: A review of the literature doi:10.1080/00243639.2017.1360065

• Oral contraceptives, reproductive factors and risk of inflammatory bowel disease doi:10.1136/gutjnl-2012-302362

• Combined oral contraceptive use and the risk of systemic lupus erythematosus doi:10.1002/art.24398

• Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility doi:10.1371/journal.pone.0149094

• The Experience of Surviving a High-Risk Pregnancy doi:10.1080/23293691.2016.1166104

• Effects of 0.9 mg Recombinant Human Thyrotropin on Thyroid Size and Function in Normal Subjects: A Randomized, Double-Blind, Cross-Over Trial doi:10.1210/jc.2004-0914